Connection
Nicholas Di bella to Recurrence
This is a "connection" page, showing publications Nicholas Di bella has written about Recurrence.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.070 |
|
|
|
-
Di Bella N, Taetle R, Kolibaba K, Boyd T, Raju R, Barrera D, Cochran EW, Dien PY, Lyons R, Schlegel PJ, Vukelja SJ, Boston J, Boehm KA, Wang Y, Asmar L. Results of a phase 2 study of bortezomib in patients with relapsed or refractory indolent lymphoma. Blood. 2010 Jan 21; 115(3):475-80.
Score: 0.059
-
Venkatesh H, Di Bella N, Flynn TP, Vellek MJ, Boehm KA, Asmar L. Results of a phase II multicenter trial of single-agent gemcitabine in patients with relapsed or chemotherapy-refractory Hodgkin's lymphoma. Clin Lymphoma. 2004 Sep; 5(2):110-5.
Score: 0.010